{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:46:28Z","timestamp":1791240388165,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jaad.2023.11.040","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:05:53Z","timestamp":1701432353000},"page":"739-748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study"],"prefix":"10.1016","volume":"90","author":[{"given":"Nikolaus B.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Knierim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Luttermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir S.","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Gassenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Forschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Eigentler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Forchhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Flatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2023.11.040_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI116278","article-title":"Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion","volume":"91","author":"Ferradini","year":"1993","journal-title":"J Clin Invest"},{"issue":"15","key":"10.1016\/j.jaad.2023.11.040_bib2","first-page":"3569","article-title":"Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma","volume":"53","author":"Mackensen","year":"1993","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.040_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1172\/JCI117116","article-title":"Direct evidence to support the immunosurveillance concept in a human regressive melanoma","volume":"93","author":"Mackensen","year":"1994","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.040_bib4","first-page":"541","article-title":"Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression","volume":"78","author":"Wagner","year":"1998","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.040_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1245\/s10434-007-9675-2","article-title":"Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy","volume":"15","author":"Morris","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.040_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jcp.2007.049411","article-title":"The correlation of regression in primary melanoma with sentinel lymph node status","volume":"61","author":"Kaur","year":"2008","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.040_bib7","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/bjd.12586","article-title":"Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients","volume":"169","author":"Ribero","year":"2013","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2023.11.040_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamadermatol.2015.2235","article-title":"Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis","volume":"151","author":"Ribero","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.040_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/labinvest.2017.8","article-title":"Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance","volume":"97","author":"Aung","year":"2017","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.040_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2018.06.054","article-title":"Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness","volume":"80","author":"Ribero","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.040_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000658-198808000-00004","article-title":"Lethal \u201cthin\u201d malignant melanoma. Identifying patients at risk","volume":"208","author":"Slingluff","year":"1988","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.040_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2559.1989.tb03076.x","article-title":"Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases","volume":"15","author":"Shaw","year":"1989","journal-title":"Histopathology"},{"key":"10.1016\/j.jaad.2023.11.040_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.1961.63040140016019a","article-title":"Metastatic melanoma with indeterminate primary site. Report of two instances of long-term survival","volume":"176","author":"Pack","year":"1961","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jaad.2023.11.040_bib14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R","article-title":"Spontaneous regression of primary malignant melanomas with regional metastases","volume":"18","author":"Smith","year":"1965","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.040_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00006534-199203000-00028","article-title":"Complete spontaneous regression of cutaneous primary malignant melanoma","volume":"89","author":"Bottger","year":"1992","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.040_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1524-4725.1994.tb01635.x","article-title":"Metastatic malignant melanoma with spontaneous and complete regression of the primary lesion. Case report and review of the literature","volume":"20","author":"Shai","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.jaad.2023.11.040_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2005.03.006","article-title":"Completely regressed primary cutaneous malignant melanoma with nodal and\/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria","volume":"53","author":"High","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.040_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/DAD.0b013e318165641a","article-title":"Complete regression of primary malignant melanoma","volume":"30","author":"Emanuel","year":"2008","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.040_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2559.1990.tb00757.x","article-title":"Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis","volume":"17","author":"Blessing","year":"1990","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.040_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/msy.2001.115830","article-title":"Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma","volume":"130","author":"McMasters","year":"2001","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.040_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/CMR.0b013e328353e673","article-title":"Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma","volume":"22","author":"McClain","year":"2012","journal-title":"Melanoma Res"},{"issue":"8","key":"10.1016\/j.jaad.2023.11.040_bib22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/jamadermatol.2013.9856","article-title":"Correlation of histologic regression in primary melanoma with sentinel node status","volume":"150","author":"Botella-Estrada","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"36","key":"10.1016\/j.jaad.2023.11.040_bib23","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.040_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ddg.13247","article-title":"S3-Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms \u2013 Update 2015\/2016, Kurzversion 2.0","volume":"15","author":"Eigentler","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.040_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0560.1993.tb00228.x","article-title":"Histologic regression in malignant melanoma: an interobserver concordance study","volume":"20","author":"Kang","year":"1993","journal-title":"J Cutan Pathol"},{"issue":"12","key":"10.1016\/j.jaad.2023.11.040_bib26","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/jdv.13815","article-title":"Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis","volume":"30","author":"Ribero","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2023.11.040_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/000313481107700819","article-title":"Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma","volume":"77","author":"Burton","year":"2011","journal-title":"Am Surg"},{"issue":"9","key":"10.1016\/j.jaad.2023.11.040_bib28","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/1097-0142(19851101)56:9<2287::AID-CNCR2820560924>3.0.CO;2-Y","article-title":"Regression in malignant melanoma. A histologic feature without independent prognostic significance","volume":"56","author":"Kelly","year":"1985","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.040_bib29","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/1097-0142(197811)42:5<2282::AID-CNCR2820420528>3.0.CO;2-V","article-title":"The regressing thin malignant melanoma: a distinctive lesion with metastatic potential","volume":"42","author":"Gromet","year":"1978","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jaad.2023.11.040_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0001-7310(09)72549-9","article-title":"Problems in defining melanoma regression and prognostic implication. Article in Spanish","volume":"100","author":"Requena","year":"2009","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.040_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2559.1992.tb00988.x","article-title":"Histological regression in primary cutaneous melanoma: recognition, prevalence and significance","volume":"20","author":"Blessing","year":"1992","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.jaad.2023.11.040_bib32","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/cncr.22295","article-title":"Predicting sentinel node status in AJCC stage I\/II primary cutaneous melanoma","volume":"107","author":"Kruper","year":"2006","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.jaad.2023.11.040_bib33","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ejca.2009.05.034","article-title":"Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database","volume":"45","author":"Mandal\u00e0","year":"2009","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.040_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.amjsurg.2011.06.048","article-title":"Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker","volume":"202","author":"Callender","year":"2011","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.040_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1529-8019.2005.00044.x","article-title":"Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features","volume":"18","author":"Elder","year":"2005","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.040_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archsurg.1983.01390010031008","article-title":"Biologic behavior of thin malignant melanomas with regressive changes","volume":"118","author":"Paladugu","year":"1983","journal-title":"Arch Surg"},{"issue":"2-3","key":"10.1016\/j.jaad.2023.11.040_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00707986","article-title":"Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases","volume":"408","author":"S\u00f8ndergaard","year":"1985","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.040_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1097-0142(19860201)57:3<545::AID-CNCR2820570323>3.0.CO;2-K","article-title":"Recurrence potential of thin primary melanomas","volume":"57","author":"Naruns","year":"1986","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jaad.2023.11.040_bib39","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archderm.1987.01660340088026","article-title":"Thin malignant melanomas with regression and metastases","volume":"123","author":"Ronan","year":"1987","journal-title":"Arch Dermatol"},{"issue":"24","key":"10.1016\/j.jaad.2023.11.040_bib40","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.040_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00008390-200306000-00005","article-title":"Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression","volume":"13","author":"Dissemond","year":"2003","journal-title":"Melanoma Res"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.040_bib42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ijc.1491","article-title":"Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A\/MART-1","volume":"94","author":"Saleh","year":"2001","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.040_bib43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.190.5.651","volume":"190","author":"Anichini","year":"1999","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.040_bib44","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<538::AID-IJC16>3.0.CO;2-G","article-title":"Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides","volume":"86","author":"J\u00e4ger","year":"2000","journal-title":"Int J Cancer"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223032504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223032504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:31:16Z","timestamp":1759275076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223032504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0190962223032504"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.11.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}